Diagnostic efficacy of 18F-FDG PET/CT in patients with adrenal incidentaloma. Issue 7 (July 2019)

• Record Type: Journal Article
• Authors: Akkuş, Gamze; Güney, Isa Burak; Ok, Fesih; Evran, Mehtap; Izol, Volkan; Erdoğan, Şeyda; Bayazıt, Yıldırım; Sert, Murat; Tetiker, Tamer
• Is Part Of: Endocrine connections. Volume 8:Issue 7(2019)
• Page Start: 838
• Page End: 845
• Publication Date: 2019-07
• Subjects: 18F-FDG PET-CT -- Cushing syndrome(s) -- pheochromocytoma(s) -- non-functional adrenal adenomas; Endocrinology -- Periodicals; 616.4005
• DOI: 10.1530/EC-19-0204
• Languages: English
• ISSNs: 2049-3614

Abstract

Abstract : Background: The management of adrenal incidentaloma is still a challenge with respect to determining its functionality (hormone secretion) and malignancy. In this light, we performed 18 F-FDG PET/CT scan to assess the SUVmax values in different adrenal masses including Cushing syndrome, pheochromocytoma, primary hyperaldosteronism and non-functional adrenal adenomas. Methods: Total 109 (73 F, 36 M) patients with adrenal mass (incidentaloma), mean age of 53.3 ± 10.2 years (range, 24–70) were screened by 18 F-FDG PET/CT. Data of 18 F-FDG PET/CT imaging of the patients were assessed by the same specialist. Adrenal masses were identified according to the calculated standardized uptake values (SUVs). Clinical examination, 24-h urine cortisol, catecholamine metabolites, 1-mg dexamethasone suppression test, aldosterone/renin ratio and serum electrolytes were analyzed. Results: Based on the clinical and hormonal evaluations, there were 100 patients with non-functional adrenal mass, four with cortisol-secreting, four with pheochromocytomas and one with aldosterone-secreting adenoma. Mean adrenal mass diameter of 109 patients was 2.1 ± 4.3 (range, 1–6.5 cm). The 18 F-FDG PET/CT imaging of the patients revealed that lower SUVmax values were found in non-functional adrenal masses (SUVmax 3.2) when compared to the functional adrenal masses including four with cortisol-secreting adenoma (SUVmax 10.1); four with pheochromcytoma (SUVmax 8.7) and one with aldosterone-secreting adenomas (SUVmax 3.30). Cortisol-secreting (Cushing syndrome) adrenal masses showed the highest SUVmax value (10.1), and a cut-off SUVmax of 4.135 was found with an 84.6% sensitivity and 75.6% specificity cortisol-secreting adrenal adenoma. Conclusions: Consistent with the similar studies, non-functional adrenal adenomas typically do not show increased FDG uptake and a certain form of functional adenoma could present various FDG uptake in FDG PET/CT. Especially functional adrenal adenomas (cortisol secreting was the highest) showed increased FDG uptake in comparison to the non-functional adrenal masses. Therefore, setting a specific SUVmax value in the differentiation of malignant adrenal lesion from the benign one is risky and further studies, including a high number of functional adrenal mass are needed.